What was the net profit for the year ended March 31, 2026?

Mercury Laboratories reported a net profit of **₹4.93 crore**, representing a **59%** increase over the previous year's **₹3.10 crore**.

Did the board announce a dividend?

Yes, the board recommended a final dividend of **35%**.

Were there any surprises in the audit report?

No. The auditors provided an unmodified opinion, and the re-appointment of internal and cost auditors was routine.

Does this filing contain new business developments?

No. The filing is a standard periodic disclosure under SEBI regulations and contains no material new business developments.

Earnings · Pharmaceuticals · Micro cap

Mercury Laboratories lifts annual profit by 59% to ₹4.93 crore

The pharmaceutical firm reported an annual net profit of ₹4.93 crore, up from ₹3.10 crore in the prior year, alongside a 35% dividend recommendation.

— 1 earlier story on Mercury Laboratories Ltd. →

MERCURYLAB By Tipsheet Editorial 29 May 2026 · 4:17 PM IST Verify on BSE · NSE

Mkt cap₹91.61 cr

P/E19.42×

ROE5.87%

Debt / eq.0.08

Div yld0.46%

₹4.93 cr Annual net profit for the year ended March 31, 2026.

What's new

Annual net profit rose 59% to ₹4.93 crore from ₹3.10 crore.
The board recommended a 35% final dividend for shareholders.
Auditors issued an unmodified opinion on the annual financial results.

Why this matters

The results show steady growth for the nano-cap pharmaceutical company. However, the figures and the routine re-appointment of auditors align with market expectations, leaving little to surprise investors.

What we're watching

Any shift in dividend policy in future quarters.
Operational updates beyond standard financial disclosures.
Volume trends for the stock following the earnings release.

The full read

Mercury Laboratories posted an annual net profit of ₹4.93 crore for the year ended March 31, 2026. This marks a 59% increase from the ₹3.10 crore reported in the previous year.

It is a routine update.

Alongside the earnings, the board recommended a 35% final dividend, while the filing includes an unmodified audit opinion and confirms the routine re-appointment of internal and cost auditors. These results are standard periodic disclosures under SEBI LODR regulations, and because the company's performance is entirely consistent with market expectations, there are no unexpected developments or new business initiatives to report.

Questions answered

What was the net profit for the year ended March 31, 2026?: Mercury Laboratories reported a net profit of ₹4.93 crore, representing a 59% increase over the previous year's ₹3.10 crore.
Did the board announce a dividend?: Yes, the board recommended a final dividend of 35%.
Were there any surprises in the audit report?: No. The auditors provided an unmodified opinion, and the re-appointment of internal and cost auditors was routine.
Does this filing contain new business developments?: No. The filing is a standard periodic disclosure under SEBI regulations and contains no material new business developments.

Mentioned: Mercury Laboratories Ltd. · March 31, 2026

Primary source BSE · NSE

An independent reading of the company's own disclosure — the primary filing above is the final word.

Story so far

All notes on MERCURYLAB →

29 May 2026 · 4:17 PM IST Mercury Laboratories lifts annual profit by 59% to ₹4.93 crore
1d ago Mercury Laboratories profit jumps 54% as revenue stays flat